Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
You can add this product to your shopping cart now, but it will not be shipped until we have received your valid prescription
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Wegovy, a prescription GLP-1 receptor agonist medication, has become a popular tool for chronic weight management
Research Overview Early clinical and preclinical investigations suggest that triple incretin agonists may produce different signalling responses compared to GLP-1 or dual GIP/GLP-1 agonists alone
